Products for Research Use Only
RegisterLogin

NBDHEX

CAT: 0804-HY-135318-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-135318-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
NBDHEX is a potent glutathione S-transferase P1-1 (GSTP1-1) inhibitor. NBDHEX induces apoptosis of tumor cells. NBDHEX acts as an anticancer agent by inhibiting GSTs catalytic activity, avoiding inconvenience of the inhibitor extrusion from the cell by specific pumps and disrupting the interaction between the GSTP1-1 and key signaling effectors. NBDHEX can also act as late-phase autophagy inhibitor[1][2].
CAS Number
787634-60-0
UNSPSC
12352005
Target
Apoptosis; Autophagy; Glutathione S-transferase
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nbdhex.html
Purity
98.56
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
OCCCCCCSC1=CC=C([N+]([O-])=O)C2=NON=C21
Molecular Formula
C12H15N3O4S
Molecular Weight
297.33
References & Citations
[1]Sha HH, et al. 6- (7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol: a promising new anticancer compound. Biosci Rep. 2018 Feb 13;38 (1) . pii: BSR20171440.|[2] Filomeni G, et al. 6- (7-Nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR) -associated protein 1-mediated MDR in small cell lung cancer. Mol Cancer Ther. 2008 Feb;7 (2) :371-9.|[3]Pellizzari Tregno F, et al. In vitro and in vivo efficacy of 6- (7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol (NBDHEX) on human melanoma. Eur J Cancer. 2009 Sep;45 (14) :2606-17.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
BUP04362-01NBDHEX

Popular Products